Recombinant CCR4 (Mogamulizumab Biosimilar) antibody

Catalog No. ABIN7675712

The Human Monoclonal anti-CCR4 (Mogamulizumab Biosimilar) antibody has been validated for FACS, ELISA, BLI, Func and SPR. It is suitable to detect CCR4 (Mogamulizumab Biosimilar) in samples from Human.

Quick Overview for Recombinant CCR4 (Mogamulizumab Biosimilar) antibody (ABIN7675712)

Target: CCR4 (Mogamulizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This CCR4 (Mogamulizumab Biosimilar) antibody is un-conjugated

Application: Flow Cytometry (FACS), ELISA, Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-CCR4 (Mogamulizumab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-CCR4 / CD194 Reference Antibody (mogamulizumab)

Characteristics: Anti-CCR4 / CD194 Reference Antibody (mogamulizumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 144.12 kDa.

Purity: >95 %

Isotype: IgG1

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for CCR4 (Mogamulizumab Biosimilar)

Target: CCR4 (Mogamulizumab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 144.12 kDa

UniProt: P51679